Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2023

Feb 2, 2023

34999_dirs_2023-02-02_c2ea828b-f6f2-4518-a0b3-f50a73e5b1f0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2023-02-01

Reporting Person: Karkus Ted William (Director, CEO & CHAIRMAN, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-01 Common Stock, par value $0.005 M 500000 $0.6 Acquired 3852087 Direct
2023-02-01 Common Stock, par value $0.005 F 268337 $8.18 Disposed 3583750 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-01 Option (right to buy) $0.6 M 500000 Disposed 2023-02-22 Common Stock (500000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.005 100000 Indirect

Footnotes

F1: On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes.

F2: The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.